{
  "pmcid": "3003523",
  "config": {
    "model": "gemini",
    "strategy": "few-shot"
  },
  "usage": {
    "input": 18647,
    "output": 910
  },
  "raw_text": "```json\n{\"extractions\":[\n{\n  \"outcome\": \"Short-Form 36-Items improvement\",\n  \"intervention\": \"Certolizumab 200 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 393,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": 7.8,\n  \"intervention_standard_deviation\": 7.93,\n  \"comparator_mean\": 1.7,\n  \"comparator_standard_deviation\": 8.47\n},\n{\n  \"outcome\": \"Short-Form 36-Items improvement\",\n  \"intervention\": \"Certolizumab 400 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 390,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": 8.6,\n  \"intervention_standard_deviation\": 7.9,\n  \"comparator_mean\": 1.7,\n  \"comparator_standard_deviation\": 8.47\n},\n{\n  \"outcome\": \"Pain\",\n  \"intervention\": \"Certolizumab 400 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 390,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": 26.2,\n  \"intervention_standard_deviation\": 21.73,\n  \"comparator_mean\": 6.8,\n  \"comparator_standard_deviation\": 22.58\n},\n{\n  \"outcome\": \"Health-related quality of life improvement - Short-Form 36-Items improvement\",\n  \"intervention\": \"Certolizumab 200 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 393,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": 7.8,\n  \"intervention_standard_deviation\": 7.93,\n  \"comparator_mean\": 1.7,\n  \"comparator_standard_deviation\": 8.47\n},\n{\n  \"outcome\": \"Mental Component Summary improvement\",\n  \"intervention\": \"Certolizumab 400 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 390,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": 6.4,\n  \"intervention_standard_deviation\": 11.85,\n  \"comparator_mean\": 2.1,\n  \"comparator_standard_deviation\": 11.29\n},\n{\n  \"outcome\": \"Fatigue Assessment Scale improvement\",\n  \"intervention\": \"Certolizumab 200 mg\",\n  \"comparator\": \"Control\",\n  \"outcome_type\": \"continuous\",\n  \"intervention_events\": null,\n  \"intervention_group_size\": 393,\n  \"comparator_events\": null,\n  \"comparator_group_size\": 199,\n  \"intervention_mean\": -2.6,\n  \"intervention_standard_deviation\": null,\n  \"comparator_mean\": -0.8,\n  \"comparator_standard_deviation\": null\n}\n]}\n```",
  "extraction": [
    {
      "outcome": "Short-Form 36-Items improvement",
      "intervention": "Certolizumab 200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 393,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": 7.8,
      "intervention_standard_deviation": 7.93,
      "comparator_mean": 1.7,
      "comparator_standard_deviation": 8.47,
      "pmcid": "3003523"
    },
    {
      "outcome": "Short-Form 36-Items improvement",
      "intervention": "Certolizumab 400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 390,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": 8.6,
      "intervention_standard_deviation": 7.9,
      "comparator_mean": 1.7,
      "comparator_standard_deviation": 8.47,
      "pmcid": "3003523"
    },
    {
      "outcome": "Pain",
      "intervention": "Certolizumab 400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 390,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": 26.2,
      "intervention_standard_deviation": 21.73,
      "comparator_mean": 6.8,
      "comparator_standard_deviation": 22.58,
      "pmcid": "3003523"
    },
    {
      "outcome": "Health-related quality of life improvement - Short-Form 36-Items improvement",
      "intervention": "Certolizumab 200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 393,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": 7.8,
      "intervention_standard_deviation": 7.93,
      "comparator_mean": 1.7,
      "comparator_standard_deviation": 8.47,
      "pmcid": "3003523"
    },
    {
      "outcome": "Mental Component Summary improvement",
      "intervention": "Certolizumab 400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 390,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": 6.4,
      "intervention_standard_deviation": 11.85,
      "comparator_mean": 2.1,
      "comparator_standard_deviation": 11.29,
      "pmcid": "3003523"
    },
    {
      "outcome": "Fatigue Assessment Scale improvement",
      "intervention": "Certolizumab 200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 393,
      "comparator_events": null,
      "comparator_group_size": 199,
      "intervention_mean": -2.6,
      "intervention_standard_deviation": null,
      "comparator_mean": -0.8,
      "comparator_standard_deviation": null,
      "pmcid": "3003523"
    }
  ]
}